Skip to main content

Advertisement

Log in

Physostigmine is the Antidote for Anticholinergic Syndrome

  • The Poison Pen
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Walker A, Delle Donne A, Douglas E, Spicer K, Pluim T. Novel use of dexmedetomidine for the treatment of anticholinergic toxidrome. J Med Toxicol 2014.

  2. Dart RC, Borron SW, Caravati EM, Cobaugh DJ, Curry SC, Falk JL, et al. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med 2009;54:386–94 e1.

  3. Rasimas JJ, Smolcic EE, Cressell A, Sachdeva K, Donovan JW. Bedside toxicologic experience with physostigmine and flumazenil. Clinical Toxicology Abstract 2010

  4. Proudfoot A (2006) The early toxicology of physostigmine: a tale of beans, great men and egos. Toxicol Rev 25:99–138

    Article  CAS  PubMed  Google Scholar 

  5. Riker RR, Fraser GL (2001) Monitoring sedation, agitation, analgesia, neuromuscular blockade, and delirium in adult ICU patients. Seminars in respiratory and critical care medicine 22:189–98

    Article  CAS  PubMed  Google Scholar 

  6. Somani SM, Khalique A (1987) Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration. Drug metabolism and disposition: the biological fate of chemicals 15:627–33

    CAS  Google Scholar 

  7. Walker WE, Levy RC, Hanenson IB (1976) Physostigmine–its use and abuse. JACEP 5:436–9

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip W. Moore.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moore, P.W., Rasimas, J.J. & Donovan, J.W. Physostigmine is the Antidote for Anticholinergic Syndrome. J. Med. Toxicol. 11, 159–160 (2015). https://doi.org/10.1007/s13181-014-0442-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-014-0442-z

Keywords

Navigation